William Keller

Mr. William R.
Keller is an Independent Director at Gland Pharma Ltd., an Independent Non-Executive Director at Hua Medicine Ltd., an Independent Non-Executive Director at WuXi Biologics (Cayman), Inc., a Chairman at Coland Holdings Ltd., a President at Pharmaceutical Association of Shijiazhuang City and a Vice President at Roche Diagnóstica Brasil Ltda.
He is on the Board of Directors at Gland Pharma Ltd., Shanghai Guo Chuang Pharmaceutical Co., Ltd., Hua Medicine Ltd. and WuXi Biologics (Cayman), Inc. Mr. Keller was previously employed as an Independent Director by Wuxi PharmaTech (Cayman), Inc., a Member-Supervisory Board by TaiGen Biopharmaceuticals Holdings Ltd., a Chairman by Coland Pharmaceutical Co., Ltd., an Independent Director by Alexion Pharmaceuticals, Inc., an Independent Director by Cathay Industrial Biotech Ltd., an Independent Director by China Nuokang Bio-Pharmaceutical, Inc., a Chairman by HBM BioMed China Partners Ltd, a Deputy General Manager by Zhangjiang Biotech & Pharmaceutical Base Development Co., Ltd, a General Manager by Keller Pharma Consultancy (Shanghai) Co. Ltd., a Vice Chairman by Shanghai Association of Enterprises With Foreign Investment, a General Manager by Shanghai Roche Pharmaceutical Co., Ltd., a General Manager by Hoffmann-La Roche, Inc., a General Manager by Roche (China) Investment Co., Ltd., an Independent Director by Artisan Acquisition Corp., an Independent Director by Fosun Pharma Group Co. Ltd., a General Manager by Productos Roche SA, and a Deputy General Manager by Produtos Roche Químicos e Farmacêuticos SA. He also served on the board at Cathay Biotech, Inc. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. He received his undergraduate degree from School of Economics & Business Administration.